Stem Cell Therapy for the Treatment of Parkinson's Disease: What Promise Does it Hold?
- 1 February 2024
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Stem Cell Research & Therapy
- Vol. 19 (2) , 185-199
Abstract
Parkinson's disease (PD) is a common, progressive neurodegenerative disorder characterized by substantia nigra dopamine cell death and a varied clinical picture that affects older people. Although more than two centuries have passed since the earliest attempts to find a cure for PD, it remains an unresolved problem. With this in mind, cell replacement therapy is a new strategy for treating PD. This novel approach aims to replace degenerated dopaminergic (DAergic) neurons with new ones or provide a new source of cells that can differentiate into DAergic neurons. Induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), neural stem cells (NSCs), and embryonic stem cells (ESCs) are among the cells considered for transplantation therapies. Recently disease-modifying strategies like cell replacement therapies combined with other therapeutic approaches, such as utilizing natural compounds or biomaterials, are proposed to modify the underlying neurodegeneration. In the present review, we discuss the current advances in cell replacement therapy for PD and summarize the existing experimental and clinical evidence supporting this approach.Keywords
Funding Information
- Tabriz University of Medical Sciences, Tabriz, Iran (62528)
This publication has 118 references indexed in Scilit:
- Induced Pluripotent Stem Cell-Derived Neural Cells Survive and Mature in the Nonhuman Primate BrainCell Reports, 2013
- Efficient Generation of Functional Dopaminergic Neurons from Human Induced Pluripotent Stem Cells Under Defined ConditionsStem Cells, 2010
- Optimizing the success of cell transplantation therapy for strokeNeurobiology of Disease, 2010
- Naive and Primed Pluripotent StatesCell Stem Cell, 2009
- Parkinson's Disease Patient-Derived Induced Pluripotent Stem Cells Free of Viral Reprogramming FactorsCell, 2009
- Disease-Specific Induced Pluripotent Stem CellsCell, 2008
- Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's diseaseProceedings of the National Academy of Sciences, 2008
- Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cellsProceedings of the National Academy of Sciences, 2008
- Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cellsProceedings of the National Academy of Sciences, 2007
- RETRACTED ARTICLE: Pluripotency of mesenchymal stem cells derived from adult marrowNature, 2002